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Summary
Objective: To develop transgenic mice harboring mutations in the COMP gene as animal models for pseudoachondroplasia (PSACH) and
multiple epiphyseal dysplasia (MED), autosomal dominant disorders characterized by early onset osteoarthritis and epiphyseal abnormali-
ties. As a first step in generating a mouse model for COMP mutations, we have cloned the cDNA of mouse COMP and examined its tissue
expression pattern.
Design: Total mRNA was isolated from the skeletal tissues of newborn C57BL/6j mice and used as a template for oligo(dT) first-strand cDNA
synthesis. The cDNA was used for PCR amplification of COMP using three oligonucleotide primer pairs designed from the published rat
COMP cDNA sequence. Nested PCR was used to complete the sequence between the amplified fragments. The entire cDNA was
sequenced and the expression pattern of the corresponding transcripts examined by Northern hybridizations.
Results: A full-length COMP cDNA was isolated. Analysis showed that the entire translated region of the mouse COMP gene is 2268 bp and
the derived amino acid sequence shows 90% homology to human COMP. Of eight adult mouse non-cartilage tissues tested, COMP
expression was detected only in testis. © 2000 OsteoArthritis Research Society International
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Cartilage oligomeric matrix protein (COMP) is an
N-terminal disulfide-linked, 524 kd homopentameric glyco-
protein found primarily surrounding chondrocytes in the
cartilage extracellular matrix.1 COMP is a member of the
thrombospondin family,2,3,4 whose members all contain a
series of polypeptide domains, termed type II-repeats, that
are homologous to epidermal growth factor (EGF), followed
by a series of repeats, termed type III-repeats, that contain
an EF-hand Ca+2-binding sequence.
Pseudoachondroplasia (PSACH) and multiple epiphy-
seal dysplasia (MED) are autosomal dominant diseases
characterized primarily by short-limb dwarfism apparent
in early childhood.5 PSACH is also associated with
deformities of the epiphyseal centers in the knees, hands,
shoulders, and hips, and with vertebral abnormalities that
result in scoliosis. MED is a milder dysplasia of the epiphy-236ses of peripheral joints. In both disorders, degeneration
of the articular cartilage leads to the early onset of osteo-
arthritis. MED and PSACH are members of the same bone
dysplasia family and have been mapped to a common
region on chromosome 19 that corresponds to the human
COMP gene locus.6–8 Subsequent studies have shown that
many patients with PSACH and MED have mutations in the
type III-repeats of the COMP gene.9–16
The Ca+2-binding type III-repeats of COMP have been
suggested to play an important role in maintaining
the integrity of the cartilage matrix, since many of the
COMP gene mutations responsible for PSACH and MED
are either deletions or substitutions of the conserved
aspartate residues in the type III-repeats. Ca+2-binding
activity is likely to be compromised in the mutated COMP,
although the exact biological function of COMP and the
contribution of the mutated COMP gene products to the
chondrodysplasia seen in PSACH and MED patients are
unknown.
To understand the mechanisms underlying the pheno-
type caused by COMP mutations, it is critical to generate
transgenic mouse models to study how these mutations
cause the structural alterations in cartilage, which lead to
chondrodysplasia. As a first step to generating these
mouse models, we report here the cloning of mouse COMP
cDNA, analysis of its coding sequence, and its tissue
expression pattern.
Osteoarthritis and Cartilage Vol. 8 No. 3 237Fig. 1. (A) Map of COMP clones obtained using RT-PCR of mouse mRNA. The clones produced from primers derived from the published
rat sequence are shown in gray. The clones produced from primers derived from the mouse sequence are shown in black. White represents
the portions of the genomic clones, E27 and E55, which contain the 5′-end regulatory region and the 3′ end, respectively. (B) Nucleotide
sequence and corresponding amino acid sequence of mouse COMP. The sites for potential N-linked glycosylation are boxed and the RGD
sequence is underlined.
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CLONING OF MOUSE COMP cDNA BY REVERSE TRANSCRIPTION
POLYMERASE CHAIN REACTION
Total mRNA was isolated from the skeleton of newborn
C57BL/6j mice using the Rex Total RNA Extraction kit
(USB), and the PolyA Tract kit (Promega) was used as a
template for oligo(dT)-primed first-strand cDNA synthesis
using the Superscript Preamplification System (Gibco
BRL). Following removal of the mRNA template with
RNaseH, the cDNA was used for PCR amplification of
mouse COMP using three oligonucleotide primer pairs
(IDT), JK1 (Forward: ACGGTGATGGAATGTGACGC,
Reverse: TGGCAGCCTGACCTCTGGTC), JK2 (Forward:
CAACTCCGATAAAGACAAGT, Reverse: ATCTTGTCTA
TAACCTTGTC), and JK3 (Forward: GGCCTGGCTGT
GGGTTACACGGC, Reverse: GGAGAAGCAGAAGAC
ACCCAGGCGG) designed from the published rat COMP
cDNA sequence (GenBank No. X72914). The PCR mixture
contained cDNA template, 1 M of each primer, 0.2 mM of
each dNTP (Perkin-Elmer), and Taq DNA Polymerase
(Boehringer-Mannheim).
The RT-PCR generated three fragments of mouse
COMP cDNA, with sequence gaps between the clones. To
recover the two gaps, we used nested PCR with four
additional primer pairs (IDT), JK4 (Forward: AACTCG
GACAGTGATAACTGG, Reverse: ATGACCACGTAGAA
GCTGGAG)/JK5 (Forward: AAGATACACACCTGGAT
GGC, Reverse: GTCCTGGTAGCCAAAGATGAAG) and
JK6 (Forward: TGCACCGACGTTAATGAGTG, Reverse:
ATCCCCAACACCATCACCATC)/JK7 (Forward: ATCAA
TACCAGCCCTGGCTTTC, Reverse: TCACTCTGGTCA
AAGTTGGG) derived from the sequence of the three
mouse cDNA clones. All PCR products were purified using
Centricon-100 (Centricon) before sequence determination.
The 242-nucleotide sequence at the 5′-end of the trans-
lated region, the 482 nucleotide sequence upstream from
the ATG start codon, and the 61-nucleotide sequence at the
3′-end of the translated region of mouse COMP were
derived using a mouse COMP genomic clone. This clone
was cut with Eco RI and subcloned in two pieces, E27,
containing the 5′-end of the clone and E55, containing
the 3′-end of the clone. This genomic clone was initially
identified from a mouse Phage Artificial Chromosome
(PAC) library (Research Genetics) by PCR using primers
designed from the published rat sequence (sense: ACGGT
GATGGAATGTGACGC; antisense: CGTCGGTCGAGTG
CGAGCCGTTGC).
All DNA sequencing was performed by the institutional
sequencing facility using the dideoxynucleotide method.NORTHERN HYBRIDIZATION ANALYSIS OF COMP EXPRESSION
Total RNA was extracted from adult mouse cartilage and
a multi-tissue blot (Clontech; poly-A+ RNA from heart,
brain, spleen, lung, liver, skeletal muscle, kidney, and
testis) was hybridized with a random-primed [32P]-labeled,
700 bp fragment of mouse COMP cDNA (bp 1464–2097)
generated by nested PCR using JK4 and JK5 primers.Results and discussion
NUCLEOTIDE AND AMINO ACID SEQUENCE OF MOUSE COMP
The five cDNA fragments generated by PCR and the
partial DNA fragments of E27 and E55 shown in Fig. 1Awere used to determine the complete nucleotide sequence
of mouse COMP cDNA, including 482 nucleotides
upstream of the ATG start codon (Fig. 1B). The translated
sequence of mouse COMP is 2268 bp corresponding to
756 amino acids (Fig. 1B).
The mouse and human (GenBank No. L32137) COMP
coding sequences are similar in size, with the former being
six nucleotides shorter, and in nucleotide homology (86%)
and amino acid homology (90%). Two types of repeating
sequences, type II-repeats and type III-repeats, are found
within mouse COMP. There are four type II-repeats with
86% homology to those in human COMP, and conservation
of all 24 of the cysteine residues required for proper folding.
There are eight contiguous Ca+2-binding type III-repeats
spanning from Gly-265 to Ala-522. The mouse and human
COMP type III-repeats have 91% homology over the entire
domain with many conserved aspartate-residues, suggest-
ing the importance of the Ca+2-binding region to the
function of COMP. Also conserved are two cysteine resi-
dues in each type III repeat, suggesting their structural
importance to the function and activity of the molecule.
Thus, a mutation in one of these residues may be respon-
sible for the PSACH and MED phenotype. Interestingly, the
third type III repeat of mouse COMP has an Arg-Gly-Asp
(RGD) integrin-binding motif, which is also present in
human COMP.4
There is also conservation of N-linked glycosylation sites
between mouse and human COMP. The three potential
sites for N-linked glycosylation at Asp-119, -142, and -740
of mouse COMP are the same as those found in the human
COMP sequence.4Fig. 2. Expression of mouse COMP in adult mouse tissues.
Northern blot of poly A+ RNA from adult mouse heart (h), brain (b),
spleen (s), lung (lu), liver (li), skeletal muscle (m), kidney (k), and
testis (t) hybridized with a 700 bp mouse COMP probe. Size
markers (kb) are indicated. Only testis mRNA showed a 2.6 kb
transcript, similar in size to that in cartilage (c).TISSUE EXPRESSION PATTERNS OF MOUSE COMP
Northern analysis of eight adult non-cartilage tissues,
heart, brain, spleen, lung, liver, skeletal muscle, kidney, and
testis, revealed an intense 2.6 kb transcript only in testis,
comparable in size to that found in cartilage (Fig. 2).
Expression of COMP in the testis has not been previously
described and there is no documentation of testicular or
reproductive abnormalities in MED and PSACH patients.
Whether a high level of tissue-specific COMP expression is
related to testicular function remains to be studied.
In conclusion, availability of the mouse COMP cDNA
should enable us to generate transgenic mice harboring
mutant COMP. Given the structural homology between
Osteoarthritis and Cartilage Vol. 8 No. 3 239human and mouse COMP, these animals should serve as
useful experimental models to examine the functional role
of COMP and the mechanisms by which COMP mutations
result in MED and PSACH phenotypes.Acknowledgments
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